Get Our Latest Stock Report on PIPR Piper Sandler Companies Trading Up 0.7 % Shares of NYSE:PIPR opened at $301.43 on Friday. The company has a market cap of $5.36 billion, a price-to-earnings ...

Piper Sandler analyst Korinne Wolfmeyer reiterated a Hold rating on Airsculpt Technologies, Inc. (AIRS – Research Report) today and set a price target of $5.00. The company’s shares closed ...

In a report released today, Stephen Scouten from Piper Sandler maintained a Buy rating on USCB Financial Holdings, Inc. Class A (USCB – Research Report), with a price target of $24.00.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...

Trupanion (NASDAQ:TRUP) shares rallied more than 4% Thursday following an upgrade from Piper Sandler analysts, who shifted their rating to Overweight from Neutral. In a note, the analysts cited ...

Investing.com -- Piper Sandler downgraded Biogen Inc (NASDAQ:BIIB) from “overweight” to “neutral,” given a challenging transition period for the biotech firm. The brokerage hacked the ...

Pets insurance company Trupanion (NASDAQ:TRUP) was upgraded at Piper Sandler on improving investor sentiment and several favorable catalysts. The catalysts include the 2025 guidance, faster-than ...

Boston Beer Company (NYSE:SAM) swung lower in early trading on Thursday after Piper Sandler downgraded the beverage stock to Neutral from a prior perch of Overweight. The firm highlighted the ...

Fintel reports that on January 10, 2025, Piper Sandler initiated coverage of ResMed Inc. - Depositary Receipt () (OTCPK:RSMDF) with a Neutral recommendation. Analyst Price Forecast Suggests 38.96% ...

MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, will release its fourth quarter and full year 2024 financial results prior to the opening of the ...

On Friday, Piper Sandler reaffirmed an Overweight stock rating for Amerant Bancorp Inc (NYSE:NYSE:AMTB) with a steady price target of $33.00, representing significant upside from the current ...